Introduction
TLC and CLC were petrolether:ethylacetate=1:1 (S 1 ), dichloromethane:methanol=20:1 (S 2 ), petrolether:ethylacetate=4:1 (S 3 ), petrolether:ethylacetate=5:1 (S 4 ).
The electron impact mass spectra were recorded with an EXTREL FTMS (Madison, WI, USA) 2001 instrument with ionizing energy 70 eV. Elemental analyses were performed in the Central Analytic Service, Ruder Boskovic Institute, Zagreb.
1 H and 13 C NMR spectra were recorded on Varian Gemini and Unity Inova 300 MHz NMR spectrometers (Varian, Palo Alto, CA, USA). The samples were dissolved in CDCl 3 or DMSO-d 6 . The 1 H and 13 C NMR chemical shift values (δ) are expressed in ppm with respect to TMS and coupling constants ( J) in Hz. Individual 1 H and 13 C NMR resonances were assigned on the basis of chemical shifts, signal intensities, magnitude and multiplicity of resonances, H-H, H-F and C-F coupling constants as well as a series of 2D NMR experiments including HSQC and HMBC. The assignments of 1 H NMR spectra are given in Table 1, whereas 13 C NMR chemical shifts are reported in the experimental part. Conformational properties were assessed with the use of 1D difference NOE enhancements and long range J HC coupling constants.
6-(2-Hydroxypropyl)-2,4-dimethoxy-5-methylpyrimidine [3]
The solution of 2,4-dimethoxy-5,6-dimethylpyrimidine [2] (919 mg; 5.47 mmol) in tetrahydrofuran (THF) (15 ml) was cooled at -70°C and lithium diisopropylamide (LDA) (4.1 ml; 2 M LDA in THF/heptane/ethylbenzene) was added dropwise into the reaction mixture. The temperature was then raised to -55°C and the reaction mixture was stirred for 30 min. Acetaldehyde (0.37 ml; 6.56 mmol) was added and the mixture was additionally stirred for 3 h and then neutralized with glacial acetic acid. The temperature was raised to room temperature and the reaction mixture was stirred further for 15 min. The solvent was evaporated and the residual yellow oily product was extracted with CH 2 Cl 2 and water. The organic layer was dried over Na 2 SO 4 and purified on silica gel CLC using S 1 as eluent, and compound [3] (765 mg; 65 %) was isolated as yellow oil.
[3]: MS m/z 213 [MH] + ; 13 C NMR (DMSO) δ: 169.07 (C-4), 166.79 (C-6), 162.14 (C-2), 108.13 (C-5), 65.81 (C-2'), 53.94 (2-OCH 3 ), 53.78 (4-OCH 3 ), 43.45 (C-1′), 23.35 (C-3′), 9.80 (CH 3 ). Anal. calcd for C 10 H 16 N 2 O 3 : C, 56.59; H, 7.60; N, 13.20. Found: C, 56.42; H, 7.62 ; N, 13.23.
6-(2-Fluoromethyl-2-hydroxypropyl)-2,4-dimethoxy-5-methylpyrimidine [4]
The synthesis of [4] was performed by a procedure analogous to that of [3] using compound [2] (448 mg; 3.2 mmol) dissolved in THF (7 ml), LDA (2.0 ml; 2 M in THF/heptane/ethylbenzene) and fluoroacetone (0.2 ml; 3.17 mmol) as reagents. After column chromatography with S 3 , the compound [4] (337 mg; 43%) was isolated as yellow oil. H, 7.01; N, 11.47. Found: C, 54.25; H, 6.99; N, 11.49. 6-(2-Trifluoromethyl-2-hydroxypropyl)-2,4-dimethoxy-5-methylpyrimidine [5]
A procedure analogous to that used for [3] was used for the synthesis of [5]. Used reagents were: [2] (514 mg; 3.06 mmol), LDA (2.3 ml; 2 M in THF/heptane/ethylbenzene), THF (7 ml) and trifluoroacetone (0.35 ml; 3.67 mmol). After column chromatography with system S 4 , the compound [5] was isolated as yellow oil (67.7%).
[5]: MS m/z 281 [MH] + ; 13 C NMR (DMSO) δ: 169.40 (C-4), 163.06 (C-6), 161.64 (C-2), 126.63 (q, J CF =287 Hz, CF 3 ), 110.13 (C-5), 73.15 (q, J CF =27 Hz, C-2′), 54.07 (2-OCH 3 ), 54.00 (4-OCH 3 ), 38.03 (q, J CF =1 Hz, C-1′), 20.67 (q, J CF =2 Hz, C-3′), 10.19 (CH 3 ). Anal. calcd for C 11 H 15 F 3 N 2 O 3 : C, 47.14; H, 5.39; N, 10.00. Found: C, 47.23; H, 5.41; N, 3, Compound [4] (756 mg; 3.57 mmol) was dissolved in acetyl chloride (9 ml). The reaction mixture was refluxed for 5 h. Water (1 ml) was then added and the reaction mixture stirred overnight at room temperature. The solvent was evaporated at the reduced pressure and the remaining yellow oil was chromatographed on a silica gel column using S 2 as eluent. The following compounds were isolated: The procedure analogous to that used for deprotection of The procedure analogous to that used for deprotection of 
7-Hydroxy-3-methoxy-4-methylpiperido[1,2-c]-pyrimidine-1-one [17]
The mixture of [7] (250 mg; 0.95 mmol) in methanol (5 ml) was saturated with gaseous NH 3 . The flask was firmly stopped and the reaction stirred overnight at 60°C. The solvent was evaporated under reduced pressure and the product was purified on the silica gel column using S 1 system. The crystals of the bicyclic compound [17] were isolated (144 mg; 72%). 
Antiviral activity assays
Antiviral activity against VZV, CMV, HIV-1, HIV-2, vaccinia virus, vesicular stomatitis virus, Coxsackie virus B4, respiratory syncytial virus, parainfluenza-3 virus, reovirus-1, Sindbis virus and Punta Toro virus was determined essentially as described previously (De Clercq et al., 1986; Balzarini et al., 1991) . Confluent human embryonic lung (HEL) fibroblasts were grown in 96-well microtitre plates and infected with the human cytomegalovirus (HCMV) strains Davis and AD-169 at 100 PFU per well. After a 2 h incubation period, residual virus was removed and the infected cells were further incubated with the medium containing different concentrations of the tested compounds (in duplicate). After incubation for 7 days at 37°C, virus-induced cytopathogenicity was monitored microscopically after ethanol fixation and staining with Giemsa (Merck, Darmstadt, Germany). Antiviral activity was expressed as the concentration required to reduce virus-induced cytopathogenicy by 50% (EC 50 ). EC 50 values were calculated from graphic plots of the percentage of cytopathogenicity as a function of concentration of the compounds.
Cytotoxicity assays
Cytotoxicity measurements were based on the inhibition of HEL cell growth. HEL cells were seeded at a rate of 5×10 3 cells/well into 96-well microtitre plates and allowed to proliferate for 24 h. Then, medium containing different concentrations of the test compounds was added. After 3 days of incubation at 37°C, the cell number was determined with a Coulter counter (Coulter Electronics, Luton, England). The cytostatic concentration was calculated as the compound concentration required to reduce cell growth by 50% relative to the number of cells in the untreated controls (CC 50 ). CC 50 values were estimated from graphic plots of the number of cells (percentage of control) as a function of the concentration of the test compounds. Cytotoxicity was expressed as minimum cytotoxic concentration (MCC) or the compound concentration that causes a microscopically detectable alteration of cell morphology.
Antitumour activity assays
The HeLa (cervical carcinoma), MCF-7 (breast carcinoma), SW 620 (colon carcinoma), MiaPaCa-2 (pancreatic carcinoma), Hep-2 (laryngeal carcinoma) and WI 38 (diploid fibroblasts) cells were cultured as monolayers and maintained in Dulbecco's modified Eagle's medium (DMEM, Gibco, Invitrogen, USA) supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin in a humidified atmosphere with 5% CO 2 at 37°C.
The HeLa, MCF-7, SW 620, MiaPaCa-2, Hep-2 and WI 38 cells were seeded into a series of standard 96-well microtitre plates on day 0. Test agents were then added in five, 10-fold dilutions (10 8 -10 4 M) and incubated for a further 72 h. Working dilutions were freshly prepared on the day of testing. The solvent was also tested for eventual inhibitory activity by adjusting its concentration to be the same as in working concentrations. After 72 h of incubation the cell growth rate was evaluated by MTT assay (3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium bromide, Sigma, USA. Mossman et al., 1983) , which detects dehydrogenase activity in viable cells. The absorbancy (optical density, OD) was measured by a microplate reader at 570 nm. 
Cell cycle analysis.
A total of 1x10 6 cells were seeded per 100 mm plate. After 24 h the compounds [6] and [9] were added at a concentration of 5x10 6 mol/l. After 72 h the attached cells were trypsinized, combined with floating cells, washed with phosphate-buffered saline (PBS), fixed with 70% ethanol and stored at -20°C. Immediately before the analysis, the cells were washed with PBS and stained with 1 µg/ml of propidium iodide (PI) with the addition of 0.2 µg/µl of RNAse A. The stained cells were then analysed with a FACSCalibur flow cytometer (Becton Dickinson, USA) -20 000 counts were measured. The percentage of the cells in each cell cycle phase was determined using the WinMDI software (Verity Software House, Inc., USA) based on the DNA histograms. Statistical analysis was performed in Microsoft Excel (2002, Microsoft Corporation, USA) using the ANOVA single factor test.
Annexin-V test
Detection and quantification of apoptotic cells at single cell level, was performed using Annexin-V-FLUOS staining kit (Roche, Switzerland), according to the manufacturer's recommendations. After 72 h, both floating and attached cells were collected. The cells were washed with PBS, pelleted and resuspended in staining-solution (annexin-V-fluorescein labelling reagent and propidium iodide (PI) in Hepes buffer). The cells were then analysed under a fluorescence microscope. Annexin-V (green fluorescent) cells were determined to be apoptotic and Annexin-V and PI cells were determined to be necrotic. Percentage of apoptotic cells was expressed as a number of fluorescent cells in relation to the total cell number (fluorescent and non-fluorescent cells), which was set at 100%.
Results
Chemistry 2,4-Dimethoxy-5,6-dimethylpyrimidine [2], a key precursor for C-6 alkylation of the pyrimidine ring, was prepared by chlorination of 5,6-dimethylpyrimidin-2,4-dione [1] and methoxylation of the chlorinated pyrimidine derivative thus obtained using the procedure given in the literature by Schlenker (1901) (Figure 2 ). The lithiation reaction has been recognized as a useful method for introducing various functionalities into the pyrimidine moiety (Hsu & Lin, 1996; Hsu et al., 1992; Middleton, 1975) . Using this method, the new 6-acyclic chain substituted 2,4-dimethoxy-5-methylpyrimidine derivatives ( (Cetina et al., 2005) whose formation may be explained by the nucleophilic attack of the N 1 nitrogen of the pyrimidine ring on the C-4 methylene of the 4-chloro-3-hydroxybutyl side chain.
Structural determination

Conformational properties of compounds [5] and [6] as well as [4] and [12]
were assessed with the use of 1D difference NOE enhancements and long range J HC coupling constants ( Table 1 ). The saturation of of H-1′a (δ: 3.12 ppm) and H-1′b (δ: 2.74 ppm) protons in compound [5] resulted in different NOE enhancements at C5-Me group (9.2% and 1.6%, respectively, Figure 3, [5] ). Proposed conformation is stabilized by the formation of hydrogen bond between hydroxyl proton and N1.
The long range proton-carbon 3 J H1'CF3 coupling constant of 2.7 Hz in [6] clearly indicated cis geometry along the C1′=C2′ double bond (Figure 3, [6] ) (Brandt et al., 1999) . The saturation of H-1′ proton showed strong NOE enhancement at C5-Me group of 14.0% which suggested that the propenyl group adopts a conformation in which the H-1′ proton is spatially close to C5-Me group. Such an orientation places the hydroxyl group in an orientation that is predisposed for the formation of hydrogen bond with N1 ( Figure 3, [6] ).
The saturation of H-1′a and H-1′b protons in [4] resulted in a strong and equal NOE enhancement at C5-Me group of 8.8%. Restricted rotation across the C-6-C-1′ bond is supported by N-1 … H-O hydrogen bond. Saturation of H-1′a and H-1′b gave NOE enhancements at both CH 2 F protons (3.1% and 2.9%, respectively) and C3′H 3 protons (2.6% and 3.7%, respectively), which indicated that H-1′a (δ: 2.83 ppm) is closer to the CH 2 F group, while H-1′b (δ: 2.75 ppm) is spatially closer to the C3′H 3 protons. Individual saturations of H-1′a and H-1′b protons in [12] resulted in a comparable enhancement at the C5-Me group (5.0% and 3.8%, respectively), C-3′ methyl group (0.6% and 1.2%, respectively) and CH 2 F group (0.2% and 1.8%, respectively), which led us to conclude that 2-fluoromethyl-propyl group predominantly adopts a conformation where it is turned away from the pyrimidine ring. The conformation along the single bonds of the 2-fluoromethyl-propyl group in compound [12] undergoes unrestricted rotation. noted with the evaluated compounds against herpes simplex virus-1, (HSV-1 strain KOS), herpes simplex virus-2 (HSV-2 strain G), herpes simplex virus-1 (ACVresistant KOS strain), vaccinia virus, vesicular stomatitis virus, Coxsackie virus B4, respiratory syncytial virus, parainfluenza-3 virus, reovirus-1, Sindbis virus, Punta Toro virus, HIV-1 and HIV-2.
Biology
Antiviral activities
Cytostatic activities
The compounds [3]-[6], [8]-[13] and [15]-[17]
were evaluated for their activities against human malignant tumour cell lines: cervical carcinoma (HeLa), breast carcinoma (MCF-7), pancreatic carcinoma (MiaPaCa-2), laryngeal carcinoma (Hep-2), colon carcinoma (SW 620) and normal fibroblasts (WI 38) (Table 3) . Amongst all evaluated compounds 2,4-dimethoxy pyrimidine derivatives [6] and [9] showed the highest cytostatic activity (Figure 4) . Thus, compound [6] containing a trifluoro-1-propenyl side chain showed a rather marked inhibitory activity against MCF-7 cells (IC 50 =8.38 µg/ml) and somewhat lower activity against HeLa (IC 50 =22.11 µg/ml), MiaPaCa-2 (IC 50 =25.42 µg/ml) and SW 620 (IC 50 =16.01 µg/ml). However, compound [6] also exhibited cytostatic activity against normal human fibroblasts (WI 38) (IC 50 =13.47 µg/ml). The 2,4-dimethoxy pyrimidine derivative [9] with a 2-fluoromethylpropyl side chain exhibited only moderate inhibitory effect against HeLa cells S Prekupec et al.
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The key NOE enhancements and long-range C-H coupling constant are shown. The proposed conformations are probably stabilised through the formation of N1 … H-O hydrogen bond.
(IC 50 =19.73 µg/ml) and minor cytostatic activity against normal fibroblasts.
Cell cycle analysis
Flow cytometric analysis was performed after 72 h for compounds [6] and [9] at concentrations of 5x10 6 and 10 5 mol/l, respectively, to identify whether the cell arrest was caused by a specific perturbation of cell cycle-related events. DNA contents of HeLa, MCF-7 ( Figure 5 ) and WI 38 cells were measured.
The analysis showed that compound [6] increased the population of G0/G1 in MCF-7 cells and decreased the G0/G1 population in HeLa cells (Table 4) . Similarly, compound [9] increased the G0/G1 population and decreased the G2/M phase in MCF-7 and caused no significant perturbations in HeLa cells (Table 4) . However, perturbations in the cell cycle were also observed in WI 38 cells (Table 4) . [9]
Detection of apoptosis
PG (%) Wi 38 MCF-7 MiaPaCa-2
SW 620
Hep-2 HeLa -7 -6 -5 -4 -3
[6] and [9] did not induce apoptosis in the tested cell lines at concentrations of 5x10 6 and 10 5 mol/l, respectively (Table 5) . However, the Annexin V assay revealed the induction of apoptosis at higher concentrations. Compound [6] induced apoptosis at a concentration of 10 5 mol/l; about 10.8% of apoptotic cells were detected in MCF-7 and 10.3% in HeLa cells. Also, 10% of apoptotic cells were detected in MCF-7 and 12.9% in HeLa after the treatment with compound [9] at a concentration of 5x10 5 mol/l. Interestingly, the induction of apoptosis was observed in WI 38 cells only after the treatment with compound [9] at a concentration of 5x10 5 M (Table 5 ).
Discussion
New types of C-6 alkylated pyrimidine derivatives Amongst all evaluated compounds, the fluorinated acyclic pyrimidine derivatives [6] and [9] showed the best cytostatic activities. Compound [6] exhibited pronounced effect against breast carcinoma (MCF-7, IC 50 =8.38 µg/ml). It seems that the increase of cell population in G0/G1 and subsequent induction of apoptosis at higher concentrations are the main mechanisms of cell growth arrest for compound [6] in MCF-7 cells. Apoptosis was also detected in HeLa cells but, contrary to the results for MCF-7, a decrease of G0/G1 cell population was observed. Compound [9] exhibited moderate cytostatic effect against cervical carcinoma (HeLa, IC 50 =19.73 µg/ml). Interestingly, no cell cycle perturbations were observed in HeLa. The cell cycle perturbations in MCF-7 were characterized by a G0/G1 increase and a G2/M decrease. Apoptosis was detected both in HeLa and MCF-7 cells, but only at higher tested concentrations. 
